Verteporfin
Showing 1 - 25 of 126
Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Trial in Rochester
Recruiting
- Advanced Pancreatic Carcinoma
- +9 more
- Endoscopic Ultrasound
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 13, 2022
Glioblastoma, Recurrent Glioblastoma Trial in Atlanta (Verteporfin)
Recruiting
- Glioblastoma
- Recurrent Glioblastoma
- Verteporfin
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Feb 17, 2022
Recurrent Prostate Cancer Trial in Philadelphia, Toronto, London (Verteporfin, SpectraCure P18 System)
Recruiting
- Recurrent Prostate Cancer
- Verteporfin
- SpectraCure P18 System
-
New York, New York
- +3 more
Nov 15, 2022
Choroidal Blood Flow in Acute and Chronic Central Serous
Recruiting
- Central Serous Chorioretinopathy
- Verteporfin
-
Stavanger, NorwayStavanger University Hospital, Department of Ophthalmology
Oct 18, 2022
Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),
Not yet recruiting
- Exudative Age Related Macular Degeneration
- Ranibizumab
- +3 more
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Nov 28, 2022
Central Serous Chorioretinopathy, Therapy, Photodynamic Trial in Beijing (50% dose of photodynamic therapy, 70% dose of
Recruiting
- Central Serous Chorioretinopathy
- Therapy, Photodynamic
- 50% dose of photodynamic therapy
- 70% dose of photodynamic therapy
-
Beijing, Beijing, ChinaPeking University People's Hospital
May 21, 2022
Age-Related Maculopathy, Choroidal Neovascularization Trial in Tulsa (Ranibizumab, Verteporfin)
Completed
- Age-Related Maculopathy
- Choroidal Neovascularization
- Ranibizumab
- Verteporfin
-
Tulsa, OklahomaEagle Mountain Vision
Nov 4, 2020
Port Wine Stains Trial in Irvine (Combined Photodynamic & Pulsed Dye Laser Treatment)
Completed
- Port Wine Stains
- Combined Photodynamic & Pulsed Dye Laser Treatment
-
Irvine, CaliforniaBeckman Laser Medical Clinic,University
Oct 19, 2022
Polypoidal Choroidal Vasculopathy Trial in Shanghai, Hangzhou, Wenzhou (conbercept, Initial PDT, Delayed PDT)
Completed
- Polypoidal Choroidal Vasculopathy
- conbercept
- +2 more
-
Shanghai, Shanghai, China
- +2 more
Jul 17, 2019
Photodynamic Therapy for PDA in NV AMD
Completed
- Neovascular Age-related Macular Degeneration
- Macular Degeneration
- No Intervention
-
Durham, North CarolinaDuke Eye Center
Nov 8, 2021
Choroidal Neovascularization, Choroid Disease Trial in Palermo (Aflibercept Injection)
Completed
- Choroidal Neovascularization
- Choroid Disease
- Aflibercept Injection
-
Palermo, ItalyAzienda Ospedaliera Universitaria Policlinico Paolo Giaccone
Aug 30, 2019
Polypoidal Choroidal Vasculopathy Trial in Singapore (Aflibercept + reduced fluence photodynamic therapy (RF-PDT), Aflibercept +
Recruiting
- Polypoidal Choroidal Vasculopathy
- Aflibercept + reduced fluence photodynamic therapy (RF-PDT)
- Aflibercept + sham reduced fluence photodynamic therapy (RF-PDT)
-
Singapore, Singapore
- +2 more
Nov 14, 2022
Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM) Trial in Worldwide (Ranibizumab
Completed
- Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)
- Ranibizumab 0.5mg
- +2 more
-
Beijing, Beijing, China
- +46 more
Mar 31, 2019
Age-related Macular Degeneration, Polypoidal Choroidal Vasculopathy Trial in Worldwide (Ranibizumab, Verteporfin PDT, Sham PDT)
Completed
- Age-related Macular Degeneration
- Polypoidal Choroidal Vasculopathy
- Ranibizumab
- +2 more
-
Hong Kong, Hong Kong
- +41 more
Mar 5, 2019
Acute Central Serous Chorioretinopathy Trial in Guangzhou (577-MPL, HD-PDT)
Completed
- Acute Central Serous Chorioretinopathy
- 577-MPL
- HD-PDT
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Apr 4, 2022
Age-Related Macular Degeneration Trial in Hong Kong (Brolucizumab, Aflibercept)
Recruiting
- Age-Related Macular Degeneration
-
Hong Kong, Hong KongGrantham Hospital
Jan 25, 2023
Pleural Effusion, Malignant Trial in Lausanne (Cisplatin, liposomal, Verteporfin, Device for Intrapleural Visudyne-mediated
Terminated
- Pleural Effusion, Malignant
- Cisplatin, liposomal
- +2 more
-
Lausanne, Vaud (VD), SwitzerlandOncology Department, Centre Hospitalier Universitaire Vaudois (C
Mar 18, 2019
Metastatic Breast Cancer Trial in Boston (Verteporfin, Continuous Low-Irradiance Photodynamic Therapy (CLIPT))
Unknown status
- Metastatic Breast Cancer
- Verteporfin
- Continuous Low-Irradiance Photodynamic Therapy (CLIPT)
-
Boston, Massachusetts
- +1 more
Jul 18, 2018
Central Serous Chorioretinopathy Trial in Hong Kong
Recruiting
- Central Serous Chorioretinopathy
-
Hong Kong, Hong Kong
- +2 more
Apr 19, 2022
Polypoidal Choroidal Vasculopathy Trial in Portugal, Spain (Intravitreal Aflibercept)
Completed
- Polypoidal Choroidal Vasculopathy
- Intravitreal Aflibercept
-
Braga, Portugal
- +12 more
Jan 8, 2020
Exudative Macular Degeneration, Wet Age-related Macular Degeneration Trial in Iowa City (Doxycycline Hyclate, Placebo)
Recruiting
- Exudative Macular Degeneration
- Wet Age-related Macular Degeneration
- Doxycycline Hyclate
- Placebo
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics Department of Ophthalmolo
Apr 5, 2022
Retinoblastoma Trial in Guangzhou (photodynamic therapy)
Completed
- Retinoblastoma
- photodynamic therapy
-
Guangzhou, Guangdong, ChinaKunbei Lai
Jun 10, 2020
Radiation Retinopathy Trial in United States (0.5 mg ranibizumab, Targeted Retinal Photocoagulation (TRP))
Completed
- Radiation Retinopathy
- 0.5 mg ranibizumab
- Targeted Retinal Photocoagulation (TRP)
-
Dallas, Texas
- +3 more
Mar 24, 2021
Breast Tumors Trial in London (Verteporfin)
Completed
- Breast Neoplasms
- Verteporfin
-
London, United KingdomRoyal Free Hospital
Apr 4, 2018
Polypoidal Choroidal Vasculopathy Trial in Guangzhou (verteporfin, verteporfin and ranibizumab)
Completed
- Polypoidal Choroidal Vasculopathy
- verteporfin
- verteporfin and ranibizumab
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Mar 2, 2018